Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2015 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (256)	2/20/2015 7:30:10 PM
From: BulbaMan	Read Replies (2) \| Respond to of 407

2/20/15 Contest update The exciting Greek Debt Olympics continued today with both Dow and S&P 500 high jumpers breaking new records! Enthusiastic biotech investors took note, lifting the Contest median to a 14.60% YTD gain (vs. up 9.16% YTD a week ago). The Nasdaq Biotech Index also gained ground, closing up 10.66% YTD (vs. up 6.50% YTD a week ago), with the Nasdaq Composite Index ending up 4.64% YTD (vs. up 3.33% YTD a week ago). OLIVIER’s portfolio, up 42.99% YTD, remained the Contest leader, with GENE’s portfolio, up 39.90% YTD and OHM’s portfolio, up 37.46% YTD, holding on to second and third place. At Friday's close, an impressive 47 of the 51 Contest portfolios were in the black with 31 of the 51 continuing to beat the NBI. The 206 Contest stock picks have an average YTD gain of 12.52% Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: Following the buyout by BioMarin, RNA (Prosensa) stopped trading on 2/11/15. TOMP’s portfolio was the only holder of RNA, with an allocation of 20%. RNA investors received $17.75 in cash plus CVRs that will not be traded. Since I can’t track the CVRs, for the reallocation, I used RNA’s 2/11 closing price of $18.65 and the 2/20/15 closing prices for the remaining stocks in TOMP’s portfolio. (All corrections, especially adjustments for splits, greatly appreciated.) Have a safe & fun weekend biotechies! Peace & good health, Bulba 2/20/15 Rank Name Profit/Loss 1 OLIVIER 42,994 2 GENE 39,898 3 OHMS 37,464 4 GADGET 36,227 5 ARTHUR 29,627 6 MCBIO 27,365 7 STEVEL 27,355 8 DNASPL 27,075 9 FRED 26,589 10 MOPGCW 26,073 Week's Top 5 Gainers Symbol 2/13/15 2/20/15 Wk.%chg. EGRX 20.980 33.680 60.53% BLRX 1.870 2.420 29.41% DRNA 21.300 26.020 22.16% SRPT 12.760 15.210 19.20% XOMA 3.410 4.050 18.77% Week's Worst 5 Losers Symbol 2/13/15 2/20/15 Wk.%chg. ENUM 1.000 0.820 -18.00% GNVC 3.990 3.370 -15.54% EDT.TO 0.460 0.405 -11.96% CAPR 6.380 5.740 -10.03% MCUR 11.195 10.200 -8.89%